RETURNS ON R&D FOR 1990s NEW DRUG INTRODUCTIONS

Previously published research by two of the authors found that returns on RD indications that RD new market strategies of major pharma firms; increased alliances with the emerging biotech sector; and, the increased attention focused on the pharmaceutical industry in the political arena. Nevertheless, analysis of new drugs entering the market from 1990-1994 resulted in findings similar to the earlier research—pharmaceutical R&D is characterized...